Figures & data
Figure 1 Morphology of ME-180 cells with or without nelfinavir treatment.
![Figure 1 Morphology of ME-180 cells with or without nelfinavir treatment.](/cms/asset/b4a0438e-42ee-4671-853c-f998a75b90ab/dddt_a_12163096_f0001_c.jpg)
Figure 2 Cervical cancer cells are sensitive to nelfinavir regardless of cisplatin sensitivity.
Abbreviation: CPR, cisplatin-resistant.
![Figure 2 Cervical cancer cells are sensitive to nelfinavir regardless of cisplatin sensitivity.](/cms/asset/38eb4a0d-ebe8-4e21-bb29-fa04cc0e8c47/dddt_a_12163096_f0002_b.jpg)
Figure 3 Nelfinavir induces autophagy.
Abbreviations: CPR, cisplatin-resistant; fu, fluorescence units; ns, nonsignificant.
![Figure 3 Nelfinavir induces autophagy.](/cms/asset/4c4be693-e12a-47b0-801f-f53832224a0f/dddt_a_12163096_f0003_c.jpg)
Figure 4 Nelfinavir suppresses cervical tumor growth in vivo.
Abbreviations: CPR, cisplatin-resistant; ns, nonsignificant; PEG, polyethylene glycol.
![Figure 4 Nelfinavir suppresses cervical tumor growth in vivo.](/cms/asset/1297f1a6-648d-47ee-a048-d97ef7dbea1b/dddt_a_12163096_f0004_b.jpg)
Figure 5 Allelic suppression of core autophagy genes in cervical cancer.
Abbreviations: mRNA, messenger RNA; RNAseq, RNA sequencing.
![Figure 5 Allelic suppression of core autophagy genes in cervical cancer.](/cms/asset/2637ade0-23f8-448b-8c5b-fdf619fc62b2/dddt_a_12163096_f0005_c.jpg)